Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.

Pharmaceutical

Daiichi Sankyo

Ken Keller

Amy Todd Klug

Lerryn Trzcinski

Brian Hauser

James Felix

Rich Jones

Mila Tartakovsky

Fussy Tracy

Kevin R Forrest

Matt Siegel

Michael Grosso

Daniel Switzer

Dale E. Shuster

Stu Mackey

Scott Cleve

Michele Schmidt

Barbara Tantillo Rn Bsn

Raquel Coca Lopez

Simon King

Kara Reheis

Hayes Williams

Ken Takeshita

The Research and Development Support team at Daiichi Sankyo plays a crucial role in enhancing the efficiency and effectiveness of the pharmaceutical development process. This team focuses on data governance, clinical operations, outsourcing, and ensuring quality throughout research projects. By utilizing advanced data architecture and statistical programming, they support cross-functional collaboration and communication, ensuring innovative therapies are developed and brought to market successfully.

Research and Development Support

Leadership Team

Clinical Operations and Management

Marketing and Communications

Research and Development Support

About

Team members

Other teams at Daiichi Sankyo

Leadership Team

Clinical Operations and Management

Marketing and Communications